Personalizing precision medicine : Patients with AML perceptions about treatment decisions
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved..
BACKGROUND: This study aims to explore patients' with acute myeloid leukemia perceptions about precision medicine and their preferences for involvement in this new area of shared decision-making.
METHODS: Individual semi-structured interviews were conducted in Finland, Italy and Germany (n = 16). The study population included patients aged 24-79 years. Interviews were analyzed with thematic content analysis.
RESULTS: Patient's perceived lack of knowledge as a barrier for their involvement in decision-making. Treatment decisions were often made rapidly based on the patient's intuition and trust for the physician rather than on information, in situations that decrease the patient's decision capacity. The patients emphasized that they are in a desperate situation that makes them willing to accept treatment with low probabilities of being cured.
CONCLUSIONS: The study raised important issues regarding patients' understanding of precision medicine and challenges concerning how to involve patients in medical decision-making. Although technical advances were viewed positively, the role of the physician as an expert and person-of-trust cannot be replaced.
PRACTICE IMPLICATIONS: Regardless of patients' preferences for involvement in decision-making, information plays a crucial role for patients' perceived involvement in their care. The concepts related to precision medicine are complex and will imply challenges to patient education.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:115 |
|---|---|
| Enthalten in: |
Patient education and counseling - 115(2023) vom: 01. Okt., Seite 107883 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Grauman, Åsa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute myeloid leukemia (AML) |
|---|
| Anmerkungen: |
Date Completed 04.09.2023 Date Revised 28.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pec.2023.107883 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359227392 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359227392 | ||
| 003 | DE-627 | ||
| 005 | 20231226080426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pec.2023.107883 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1197.xml |
| 035 | |a (DE-627)NLM359227392 | ||
| 035 | |a (NLM)37421687 | ||
| 035 | |a (PII)S0738-3991(23)00263-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Grauman, Åsa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Personalizing precision medicine |b Patients with AML perceptions about treatment decisions |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.09.2023 | ||
| 500 | |a Date Revised 28.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: This study aims to explore patients' with acute myeloid leukemia perceptions about precision medicine and their preferences for involvement in this new area of shared decision-making | ||
| 520 | |a METHODS: Individual semi-structured interviews were conducted in Finland, Italy and Germany (n = 16). The study population included patients aged 24-79 years. Interviews were analyzed with thematic content analysis | ||
| 520 | |a RESULTS: Patient's perceived lack of knowledge as a barrier for their involvement in decision-making. Treatment decisions were often made rapidly based on the patient's intuition and trust for the physician rather than on information, in situations that decrease the patient's decision capacity. The patients emphasized that they are in a desperate situation that makes them willing to accept treatment with low probabilities of being cured | ||
| 520 | |a CONCLUSIONS: The study raised important issues regarding patients' understanding of precision medicine and challenges concerning how to involve patients in medical decision-making. Although technical advances were viewed positively, the role of the physician as an expert and person-of-trust cannot be replaced | ||
| 520 | |a PRACTICE IMPLICATIONS: Regardless of patients' preferences for involvement in decision-making, information plays a crucial role for patients' perceived involvement in their care. The concepts related to precision medicine are complex and will imply challenges to patient education | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Acute myeloid leukemia (AML) | |
| 650 | 4 | |a Patient perception | |
| 650 | 4 | |a Patient preferences | |
| 650 | 4 | |a Precision medicine | |
| 650 | 4 | |a Qualitative design | |
| 650 | 4 | |a Shared decision-making | |
| 700 | 1 | |a Kontro, Mika |e verfasserin |4 aut | |
| 700 | 1 | |a Haller, Karl |e verfasserin |4 aut | |
| 700 | 1 | |a Nier, Samantha |e verfasserin |4 aut | |
| 700 | 1 | |a Aakko, Sofia |e verfasserin |4 aut | |
| 700 | 1 | |a Lang, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Zingaretti, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Meggiolaro, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a De Padova, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Marconi, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Martinelli, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Heckman, Caroline A |e verfasserin |4 aut | |
| 700 | 1 | |a Simonetti, Giorgia |e verfasserin |4 aut | |
| 700 | 1 | |a Bullinger, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Kihlbom, Ulrik |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Patient education and counseling |d 1983 |g 115(2023) vom: 01. Okt., Seite 107883 |w (DE-627)NLM012798649 |x 1873-5134 |7 nnns |
| 773 | 1 | 8 | |g volume:115 |g year:2023 |g day:01 |g month:10 |g pages:107883 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pec.2023.107883 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 115 |j 2023 |b 01 |c 10 |h 107883 | ||